Published in Br J Surg on February 01, 1998
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
Bile leakage after hepatic resection. Ann Surg (2001) 2.08
Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg (2012) 1.56
Risk factors and management of bile leakage after hepatic resection. World J Surg (2003) 1.40
Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg (2006) 1.38
Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg (2011) 1.29
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01
Liver resective surgery: a multivariate analysis of postoperative outcome and complication. Langenbecks Arch Surg (2006) 0.98
Early outcome following hepatic resection in patients older than 80 years of age. World J Surg (2009) 0.93
Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB (Oxford) (2010) 0.93
Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy. World J Surg (2011) 0.93
Techniques for liver parenchymal transection: a meta-analysis of randomized controlled trials. HPB (Oxford) (2009) 0.87
A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery. HPB (Oxford) (2010) 0.86
Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis. Surg Today (2011) 0.84
Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma. World J Surg (2006) 0.84
HA/GSA-Rmax ratio as a predictor of postoperative liver failure. World J Surg (2008) 0.82
Risk factors for massive bleeding during major hepatectomy. World J Surg (2010) 0.82
Tissue damage with different surgical techniques in a porcine model of liver resection: implications for living-donor liver transplantation? J Hepatobiliary Pancreat Sci (2011) 0.80
Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg (2013) 0.80
Two hundred and forty-one consecutive liver resections: an experience from India. HPB (Oxford) (2007) 0.79
Outcome of hepatectomy for hepatocellular carcinoma in patients with renal dysfunction. HPB (Oxford) (2012) 0.78
Pure Laparoscopic Versus Open Liver Resection for Primary Liver Carcinoma in Elderly Patients: A Single-Center, Case-Matched Study. Medicine (Baltimore) (2015) 0.78
Geriatric assessment as a predictor of postoperative complications in elderly patients with hepatocellular carcinoma. Langenbecks Arch Surg (2016) 0.77
An accurate predictor of liver failure and death after hepatectomy: a single institution's experience with 478 consecutive cases. World J Gastroenterol (2014) 0.77
The Interaction between Diabetes, Body Mass Index, Hepatic Steatosis, and Risk of Liver Resection: Insulin Dependent Diabetes Is the Greatest Risk for Major Complications. HPB Surg (2014) 0.77
Serum arterial lactate concentration predicts mortality and organ dysfunction following liver resection. Perioper Med (Lond) (2013) 0.77
Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas. World J Gastroenterol (2003) 0.76
An Electrode Array for Limiting Blood Loss During Liver Resection: Optimization via Mathematical Modeling. Open Biomed Eng J (2010) 0.76
Influence of metabolic and other clinicopathologic factors on the prognosis of patients with hepatocellular carcinoma undergoing hepatic resection. Korean J Hepatobiliary Pancreat Surg (2014) 0.75
Risk factors of postoperative ascites on hepatic resection for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg (2016) 0.75
Prediction model for 30-day morbidity after gynecological malignancy surgery. PLoS One (2017) 0.75
Safe and permissible limits of hepatectomy in obstructive jaundice patients. World J Surg (2004) 0.75
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (1995) 8.12
Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc (1994) 6.86
Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci U S A (1999) 6.29
FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell (1997) 5.78
A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell (1998) 4.78
A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J (1997) 4.61
The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell (1996) 4.35
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood (2001) 3.93
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer (1998) 3.81
Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet (1999) 3.00
Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev (1998) 3.00
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86
FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell (2000) 2.86
Vascular endothelial cell lineage-specific promoter in transgenic mice. Development (1995) 2.76
Ultrasound-guided transversus abdominis plane (TAP) block. Anaesth Intensive Care (2007) 2.67
Xenopus MAP kinase activator: identification and function as a key intermediate in the phosphorylation cascade. EMBO J (1992) 2.67
Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J (2001) 2.62
A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A (1997) 2.55
Complications and diagnosis of Meckel's diverticulum in 776 patients. Am J Surg (1992) 2.48
Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg (1988) 2.31
Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells. Mol Cell Biol (1996) 2.31
A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc (2000) 2.30
Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell (2001) 2.29
Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell (1999) 2.26
A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res (1999) 2.20
Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev (1998) 2.16
Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut (2007) 2.15
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg (2000) 2.13
Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg (1994) 2.13
Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity (2001) 2.09
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer (2000) 2.08
Bile leakage after hepatic resection. Ann Surg (2001) 2.08
Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg (1984) 2.07
Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J (1997) 2.06
Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther (2015) 2.01
Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology (2008) 2.00
Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol (2000) 2.00
Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age Ageing (2000) 1.99
Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest (1993) 1.97
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res (1993) 1.96
Catalytic functionalization of arenes and alkanes via C-H bond activation. Acc Chem Res (2001) 1.95
Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group. Br J Cancer (2000) 1.93
Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development (1999) 1.92
Needle and trocar injury during laparoscopic surgery in Japan. Surg Endosc (1997) 1.92
E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol (2001) 1.91
Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg (2001) 1.90
Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res (1999) 1.88
Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg (1998) 1.88
Solitary Peutz-Jeghers type polyp of the stomach in the absence of familial polyposis coli in a teenage boy. Endoscopy (1989) 1.86
FOG-2: A novel GATA-family cofactor related to multitype zinc-finger proteins Friend of GATA-1 and U-shaped. Proc Natl Acad Sci U S A (1999) 1.83
Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery (1995) 1.82
Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F. Leukemia (2007) 1.81
Association between incremental gains in the objective response rate and survival improvement in phase III trials of first-line chemotherapy for extensive disease small-cell lung cancer. Ann Oncol (2009) 1.81
Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development (1999) 1.80
Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg (1981) 1.79
Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol (1987) 1.78
SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci U S A (1998) 1.78
Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg (1992) 1.76
The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc Natl Acad Sci U S A (1997) 1.76
Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg (1997) 1.76
Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy (2008) 1.73
Predictors of lymph node metastasis in early gastric cancer. Br J Surg (1992) 1.73
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology (1995) 1.72
Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg (1997) 1.71
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res (2000) 1.69
Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg (2010) 1.68
Pharmacokinetics of benzene and toluene. Int Arch Arbeitsmed (1974) 1.68
Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer (1997) 1.67
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer (2000) 1.67
Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology (1996) 1.64
Expression and genetic interaction of transcription factors GATA-2 and GATA-3 during development of the mouse central nervous system. Dev Biol (1999) 1.64
Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol (2002) 1.64
Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology (1991) 1.63
Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther (2003) 1.61
Liver transplantation: an unfinished product. Transplant Proc (1989) 1.61
Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene (1993) 1.60
Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias. J Cardiovasc Electrophysiol (2001) 1.59
Gastric carcinoma in patients over 70 years of age. Br J Surg (1995) 1.59
An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice. Proc Natl Acad Sci U S A (1997) 1.59
The significance of the aberrant left hepatic artery arising from the left gastric artery at curative gastrectomy for gastric cancer. Eur J Surg Oncol (2007) 1.58
Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology (1989) 1.58